Exploring Alternative Viral Vector Methods for Delivering Gene Therapies
Time: 3:45 pm
day: Day Two
Details:
- An overview of the immunogenicity issues surrounding AAV vectors and some different approaches to overcome this
- How to overcome immune barriers to gene therapy delivery via a novel viral vector method
- Discussing some of the regulatory challenges unique to developing novel viral vectors
